Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets urged to report pet exposure to human topical hormones
The VMD recommends that owners keep pets away from areas of skin where topical hormone products have been applied.

Animals can accidentally absorb hormones through everyday behaviours, like cuddling.

The Veterinary Medicines Directorate is urging vets to report incidents of pets being accidentally exposed to human topical hormone products.

The reminder is part of a series of VMD articles highlighting adverse events that often go underreported.

In this first article, the VMD highlights a review by the Swedish Medical Products Agency suggesting that pets may absorb oestrogen or testosterone by coming into contact with human skin where hormone gels and creams have been applied.

As forearms are a common application site for these treatments, everyday behaviours like cuddling or stroking pets can increase the chance of accidental absorption - a risk that many pet owners are not aware of.

Signs that a pet may have been accidentally exposed to topical hormone products vary by the animal’s sex and whether the animal absorbs oestrogen or testosterone. Female pets may show signs similar to being in heat, whether spayed or not, while males may develop swollen mammary glands and changes in testicular size.

To reduce these risks, the VMD recommends that owners keep pets away from areas of skin where topical hormone products have been applied and wash their hands with soap and water after application. The VMD also advises covering the application site with clean clothing once the product has dried.

Vets made aware of an adverse reaction after exposure to a human hormone product are urged to report it directly via the VMD’s adverse event reporting service.

It said: ‘The VMD will use reports to check if medicines continue to be safe and work as expected, to protect animal health, public health, and the environment’.

Image (C) Iryna Kalamurza/Shutterstock.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'